EIBALL Session - Jointly organised by the EIBALL and QIBA
EIBALL 14 - Clinical validation of DWI as imaging biomarkers
Lectures
1
Chairperson's introduction
05:00Nandita Desouza, London / UK
2
Problems related to the DWI as a quantitative imaging biomarker
15:00Nandita Desouza, London / UK
3
QIBA Profile on DWI
15:00Michael Boss, Boulder / US
4
How to conform to the QIBA Profile
15:00Gudrun Zahlmann, Oak Brook / US
5
Panel discussion: Is the QIBA DWI Profile ready for clinical use?
10:00Panel discussion: Is the QIBA DWI Profile ready for clinical use?
5 min
Chairperson's introduction
Nandita Desouza, London / United Kingdom
15 min
Problems related to the DWI as a quantitative imaging biomarker
Nandita Desouza, London / United Kingdom
1. To learn the potential value of quantitative DWI.
2. To appreciate the steps required to pool data for meaningful interpretation successfully.
3. To understand the limitations of quantitation to use it in AI algorithms.
2. To appreciate the steps required to pool data for meaningful interpretation successfully.
3. To understand the limitations of quantitation to use it in AI algorithms.
15 min
QIBA Profile on DWI
Michael Boss, Boulder / United States
1. To learn the purpose behind the QIBA Profile on DWI.
2. To appreciate the rigour behind the Profile's ADC claim statements.
3. To understand what successful implementation of the Profile can provide users.
2. To appreciate the rigour behind the Profile's ADC claim statements.
3. To understand what successful implementation of the Profile can provide users.
15 min
How to conform to the QIBA Profile
Gudrun Zahlmann, Oak Brook / United States
1. To learn how to implement the requirements of the QIBA Profile in a real setting.
2. To appreciate the challenges and solutions of DWI MR implementation as a quantitative imaging biomarker assessment.
3. To understand the necessary steps to be considered to assess ADC reliably and reproducibly.
2. To appreciate the challenges and solutions of DWI MR implementation as a quantitative imaging biomarker assessment.
3. To understand the necessary steps to be considered to assess ADC reliably and reproducibly.
10 min
Panel discussion: Is the QIBA DWI Profile ready for clinical use?